CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-08 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −4,630 | 66,460 | ||
| 2021-04-08 | Pierce Christopher EVP and Chief of Business Oper | Grant or award | +200 | $1.89 | $378 | 3,950 |
| 2021-04-08 | Pierce Christopher EVP and Chief of Business Oper | Sale | −200 | $40.00 | $8K | 3,750 |
| 2021-04-08 | Pierce Christopher EVP and Chief of Business Oper | Exercise or conversion · Employee Stock Option (right to buy) | −200 | 7,618 | ||
| 2021-04-08 | Morosini Deborah EVP, Chief of Clinical Affairs | Exercise or conversion | +100 | $1.89 | $189 | 544 |
| 2021-04-08 | Morosini Deborah EVP, Chief of Clinical Affairs | Sale | −100 | $40.00 | $4K | 444 |
| 2021-04-08 | Morosini Deborah EVP, Chief of Clinical Affairs | Exercise or conversion · Employee Stock Option (right to buy) | −100 | 7,546 | ||
| 2021-04-08 | Mauro David J Chief Medical Officer | Exercise or conversion | +9,617 | $1.89 | $18K | 9,617 |
| 2021-04-08 | Mauro David J Chief Medical Officer | Sale | −3,274 | $37.04 | $121K | 6,343 |
| 2021-04-08 | Mauro David J Chief Medical Officer | Sale | −1,501 | $37.83 | $57K | 4,842 |
| 2021-04-08 | Mauro David J Chief Medical Officer | Sale | −1,293 | $39.00 | $50K | 3,549 |
| 2021-04-08 | Mauro David J Chief Medical Officer | Sale | −3,549 | $39.56 | $140K | 0 |
| 2021-04-08 | Mauro David J Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −9,617 | 277,610 | ||
| 2021-04-07 | Scherle Peggy Chief Scientific Officer | Grant or award | +15,370 | $1.43 | $22K | 188,290 |
| 2021-04-07 | Scherle Peggy Chief Scientific Officer | Sale | −8,289 | $39.02 | $323K | 180,001 |
| 2021-04-07 | Scherle Peggy Chief Scientific Officer | Sale | −6,881 | $39.63 | $273K | 173,120 |
| 2021-04-07 | Scherle Peggy Chief Scientific Officer | Sale | −200 | $40.30 | $8K | 172,920 |
| 2021-04-07 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −15,370 | 71,090 | ||
| 2021-04-07 | Pierce Christopher EVP and Chief of Business Oper | Grant or award | +828 | $1.89 | $2K | 4,578 |
| 2021-04-07 | Pierce Christopher EVP and Chief of Business Oper | Sale | −828 | $40.08 | $33K | 3,750 |
Page 14 of 19 · 369 trades